GL9 Stock Chart & Stats
€21.92
-€0.16(-0.72%)
At close: 4:00 PM EDT
€21.92
-€0.16(-0.72%)
Day’s Range― - ―
52-Week Range€12.16 - €26.00
Previous CloseN/A
Volume0.00
Average Volume (3M)18.00
Market Cap
€5.46B
Enterprise Value€4.13K
Total Cash (Recent Filing)€280.89M
Total Debt (Recent Filing)€982.14M
Price to Earnings (P/E)35.8
Beta0.45
Next Earnings
Mar 03, 2027EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.50
Shares Outstanding238,914,350
10 Day Avg. Volume20
30 Day Avg. Volume18
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.83Price Target Upside8.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Glanbia News
GL9 FAQ
What was Glanbia Plc’s price range in the past 12 months?
Glanbia Plc lowest stock price was €12.16 and its highest was €26.00 in the past 12 months.
What is Glanbia Plc’s market cap?
Glanbia Plc’s market cap is €5.46B.
When is Glanbia Plc’s upcoming earnings report date?
Glanbia Plc’s upcoming earnings report date is Mar 03, 2027 which is in 205 days.
How were Glanbia Plc’s earnings last quarter?
Glanbia Plc released its earnings results on Aug 06, 2026. The company reported €0.703 earnings per share for the quarter, beating the consensus estimate of €0.607 by €0.096.
Is Glanbia Plc overvalued?
According to Wall Street analysts Glanbia Plc’s price is currently Undervalued.
Does Glanbia Plc pay dividends?
Glanbia Plc does not currently pay dividends.
What is Glanbia Plc’s EPS estimate?
Glanbia Plc’s EPS estimate is 0.68.
How many shares outstanding does Glanbia Plc have?
Glanbia Plc has 238,914,350 shares outstanding.
What happened to Glanbia Plc’s price movement after its last earnings report?
Glanbia Plc reported an EPS of €0.703 in its last earnings report, beating expectations of €0.607. Following the earnings report the stock price went down -0.453%.
Which hedge fund is a major shareholder of Glanbia Plc?
Currently, no hedge funds are holding shares in DE:GL9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glanbia Plc
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
GL9 Company Deck
GL9 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial picture: significant top-line growth, a 30% increase in adjusted EPS, upgraded guidance, strong cash conversion, and clear progress on transformation and digital initiatives. However, material near-term headwinds remain — notably record whey protein costs, some early price elasticity, supply-chain related raw material inflation (H&N) and one-off transformation charges — which management is actively addressing through pricing, procurement and efficiency measures. On balance, the positive performance, upgraded guidance and effective capital returns outweigh the challenges, but monitoring of input cost dynamics and consumer elasticity remains key.View all DE:GL9 earnings summariesGL9 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€23.83
▲(8.73% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month







